首页> 美国卫生研究院文献>other >The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.

【2h】

The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.

机译：进行性炎性脑病（CUPID）试验中的大麻素使用：一项随机的双盲安慰剂对照平行组多中心试验并对大麻素减慢多发性硬化症的进展进行经济评估。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BACKGROUNDThe Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial aimed to determine whether or not oral Δ(9)-tetrahydrocannabinol (Δ(9)-THC) slowed the course of progressive multiple sclerosis (MS); evaluate safety of cannabinoid administration; and, improve methods for testing treatments in progressive MS.

机译：背景技术在进行性炎症性脑病中使用大麻素（CUPID）试验旨在确定口服Δ（9）-四氢大麻酚（Δ（9）-THC）是否减慢了进行性多发性硬化症（MS）的进程;评估大麻素给药的安全性；改进在进行性MS中测试治疗方法的方法。

著录项

期刊名称 other
作者
Susan Ball; Jane Vickery; Jeremy Hobart; Dave Wright; Colin Green; James Shearer; Andrew Nunn; Mayam Gomez Cano; David MacManus; David Miller; Shahrukh Mallik; John Zajicek;
展开▼
作者单位

展开▼
年(卷),期 -1(19),12
年度 -1
页码 vii-viii xxv-xxxi 1-187
总页数 55
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献

1. The CUPID trial: a randomised double blind placebo-controlled parallel group multi-centre trial of cannabinoids to slow progression in multiple sclerosis [J] . Ball?S, Vickery?J, Hobart?J, Health technology assessment: HTA . 2015,第12期

机译：CUPID试验：大麻素减慢多发性硬化进程的随机双盲安慰剂对照平行组多中心试验
2. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial [J] . The lancet. Respiratory medicine. . 2020,第5期

机译：Nintedanib患者患有初步抗体性肺病疾病 - 亚组通过内联肺病诊断分析：随机，双盲，安慰剂，并联群试验
3. Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS (see comments) [J] . The Lancet . 1998,第9139期

机译：安慰剂对照多中心干扰素β-1b治疗继发性进行性多发性硬化症的随机试验。欧洲研究小组关于继发性进行性MS中干扰素β-1b的研究（请参阅评论）
4. Magnetic resonance imaging evaluation and therapeutic trials in primary progressive multiple sclerosis. [D] . Leary, Siobhan Marie. 2002

机译：原发性进行性多发性硬化症的磁共振成像评估和治疗试验。
5. Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised placebo-controlled trial [O] . John Zajicek, Susan Ball, David Wright, -1

机译：屈大麻酚对进行性多发性硬化症（CUPID）进展的影响：一项随机安慰剂对照试验
6. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis. [O] . Ball, Susan, Vickery, J, Hobart, J, 2015

机译：进行性炎性脑病（CUPID）试验中的大麻素使用：一项随机的双盲安慰剂对照平行组多中心试验，并对大麻素减慢多发性硬化症的进展进行经济评估。

The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.

摘要

著录项

相似文献

相关主题

期刊订阅